Tirzepatide
$258/mo intro
Yucca presents tirzepatide as the stronger weight-loss option in the lineup, with a higher public price, the same asynchronous provider-review flow, and the best advertised entry price tied to the longest plan.
- Higher advertised entry price than semaglutide, but positioned as the stronger option.
- Best public pricing is attached to the longest plan rather than the month-to-month offer.